Company Overview

Company name: Verda Bio
Also known as:
Description: Developer of cannabinoid medicines. The company uses analytical chemistry analysis to track compounds and proteins produced by various strains of the cannabis plant to develop medicines that cure neurotransmission and endocannabinoid system, inflammation, ion-channels, cancer cell apoptosis, angiogenesis, cell cycle genes regulation and oxidative stress reduction.
Year founded: 2013
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Seattle
State: Washington
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 0.55
Business status: Startup
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company raised $545,000 of angel funding from undisclosed investors on September 28, 2016.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: